Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

REGENXBIO - Stock Price History | RGNX

Historical daily share price chart and data for REGENXBIO since 2019 adjusted for splits. The latest closing stock price for REGENXBIO as of October 18, 2019 is 37.75.
  • The all-time high REGENXBIO stock closing price was 82.15 on July 10, 2018.
  • The REGENXBIO 52-week high stock price is 73.81, which is 95.5% above the current share price.
  • The REGENXBIO 52-week low stock price is 30.38, which is 19.5% below the current share price.
  • The average REGENXBIO stock price for the last 52 weeks is 48.06.
  
REGENXBIO Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 52.0580 34.7500 82.1500 24.0500 41.9500 26.17%
2017 22.8349 18.5000 34.6000 16.7000 33.2500 79.25%
2016 13.4967 17.0000 24.0000 7.3200 18.5500 11.75%
2015 20.6147 30.4500 30.7000 14.1500 16.6000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.437B $0.219B
REGENXBIO Inc. is a biotechnology company. The Company focuses on the development, commercialization and licensing of recombinant adeno-associated virus gene therapy. Its products candidates include RGX-501, for the treatment of homozygous familial hypercholesterolemia which uses the AAV8 vector to deliver the human low-density lipoprotein receptor gene to liver cells; RGX-111, for the treatment of Mucopolysaccharidosis Type I which uses the AAV9 vector to deliver the human a-l-iduronidase gene to the central nervous system; RGX-121, for the treatment of Mucopolysaccharidosis Type II; RGX-314, for the treatment of wet age-related macular degeneration and RGX-321, for the treatment of X-linked retinitis pigmentosa. REGENXBIO Inc. is headquartered in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.075B 13.90
Gilead Sciences (GILD) United States $82.611B 10.15
CSL (CSLLY) Australia $77.981B 0.00
Celgene (CELG) United States $72.150B 11.16
Vertex Pharmaceuticals (VRTX) United States $45.680B 49.37
Illumina (ILMN) United States $45.651B 53.64
Biogen (BIIB) United States $41.611B 7.39
Regeneron Pharmaceuticals (REGN) United States $33.122B 15.03
Alexion Pharmaceuticals (ALXN) United States $22.420B 11.82
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.379B 0.00
Incyte (INCY) United States $16.653B 49.01
Seattle Genetics (SGEN) United States $13.898B 0.00
Genmab (GNMSF) Denmark $12.636B 70.88
Exact Sciences (EXAS) United States $12.611B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.186B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.175B 54.54
Alnylam Pharmaceuticals (ALNY) United States $9.106B 0.00
Galapagos (GLPG) Belgium $8.936B 0.00
Bio-Techne Corp (TECH) United States $7.635B 52.75
Sarepta Therapeutics (SRPT) United States $6.500B 0.00
QIAGEN (QGEN) Netherlands $6.355B 20.87
BeiGene (BGNE) Cayman Islands $6.328B 0.00
Guardant Health (GH) United States $6.299B 0.00
Amarin (AMRN) Ireland $5.855B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.777B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.310B 13.50
Reata Pharmaceuticals (RETA) United States $5.214B 0.00
Exelixis (EXEL) United States $5.149B 13.39
Bluebird Bio (BLUE) United States $5.048B 0.00
Moderna (MRNA) United States $4.801B 0.00
China Biologic Products (CBPO) China $4.553B 28.42
ARGENX SE-ADR (ARGX) Netherlands $4.494B 0.00
Medicines (MDCO) United States $4.443B 0.00
Ascendis Pharma (ASND) Denmark $4.217B 0.00
Repligen (RGEN) United States $4.084B 79.26
Spark Therapeutics (ONCE) United States $3.887B 0.00
Blueprint Medicines (BPMC) United States $3.673B 0.00
MorphoSys AG (MOR) Germany $3.482B 0.00
Mirati Therapeutics (MRTX) United States $3.422B 0.00
Immunomedics (IMMU) United States $3.045B 0.00
Emergent Biosolutions (EBS) United States $2.795B 41.99
Alkermes (ALKS) Ireland $2.786B 0.00
Genmab (GMAB) Denmark $2.701B 0.00
Genomic Health (GHDX) United States $2.632B 49.36
MyoKardia (MYOK) United States $2.625B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.532B 0.00
Arena Pharmaceuticals (ARNA) United States $2.437B 5.24
Halozyme Therapeutics (HALO) United States $2.312B 0.00
Acceleron Pharma (XLRN) United States $2.279B 0.00
Myriad Genetics (MYGN) United States $2.263B 23.58
RA PHARMCTL INC (RARX) United States $2.198B 0.00
NeoGenomics (NEO) United States $2.122B 113.50
Intercept Pharmaceuticals (ICPT) United States $2.106B 0.00
Amicus Therapeutics (FOLD) United States $2.083B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.072B 0.00
Ligand Pharmaceuticals (LGND) United States $2.057B 26.00
Cambrex (CBM) United States $2.002B 25.32
Zai Lab (ZLAB) China $1.983B 0.00
Akcea Therapeutics (AKCA) United States $1.761B 0.00
UniQure (QURE) Netherlands $1.674B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.585B 0.00
Insmed (INSM) United States $1.564B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.504B 0.00
Denali Therapeutics (DNLI) United States $1.451B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.397B 0.00
Coherus BioSciences (CHRS) United States $1.339B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.210B 0.00
Zymeworks (ZYME) Canada $1.176B 0.00
Innoviva (INVA) United States $1.107B 3.20
Dicerna Pharmaceuticals (DRNA) United States $1.080B 0.00
Alector (ALEC) United States $1.036B 0.00
AnaptysBio (ANAB) United States $1.009B 0.00
Editas Medicine (EDIT) United States $1.008B 0.00
Sangamo Therapeutics (SGMO) United States $0.998B 0.00
Fate Therapeutics (FATE) United States $0.960B 0.00
Epizyme (EPZM) United States $0.953B 0.00
ANI Pharmaceuticals (ANIP) United States $0.888B 14.83
Achillion Pharmaceuticals (ACHN) United States $0.866B 0.00
Zealand Pharma (ZEAL) Denmark $0.865B 9.71
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Athenex (ATNX) United States $0.835B 0.00
Codexis (CDXS) United States $0.808B 0.00
Twist Bioscience (TWST) United States $0.806B 0.00
Anika Therapeutics (ANIK) United States $0.803B 28.43
Cara Therapeutics (CARA) United States $0.788B 0.00
Principia Biopharma (PRNB) United States $0.761B 394.00
Vanda Pharmaceuticals (VNDA) United States $0.729B 26.31
Pharming Group (PHGUF) Netherlands $0.724B 0.00
Zealand Pharma (ZLDPF) Denmark $0.722B 0.00
WAVE Life Sciences (WVE) Singapore $0.721B 0.00
Vericel (VCEL) United States $0.684B 0.00
Revance Therapeutics (RVNC) United States $0.676B 0.00
Cytokineticsorporated (CYTK) United States $0.665B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.644B 0.00
Mesoblast (MESO) Australia $0.619B 0.00
Heska (HSKA) United States $0.596B 77.27
GENFIT S.A (GNFT) France $0.560B 0.00
MiMedx (MDXG) United States $0.556B 0.00
Intellia Therapeutics (NTLA) United States $0.555B 0.00
Arvinas (ARVN) United States $0.524B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.519B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.502B 0.00
PHARMA MAR SA (PHMMF) Spain $0.494B 0.00
Retrophin (RTRX) United States $0.491B 0.00
DBV Technologies S.A (DBVT) France $0.474B 0.00
Intra-Cellular Therapies (ITCI) United States $0.469B 0.00
UROGEN PHARMA (URGN) United States $0.468B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.462B 0.00
BioDelivery Sciences (BDSI) United States $0.461B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Adverum Biotechnologies (ADVM) United States $0.454B 0.00
Cellectis S.A (CLLS) France $0.448B 0.00
Stemline Therapeutics (STML) United States $0.396B 0.00
Bellus Health (BLU) Canada $0.393B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.387B 0.00
Arcus Biosciences (RCUS) United States $0.386B 0.00
Merus (MRUS) Netherlands $0.376B 0.00
Agenus (AGEN) United States $0.368B 0.00
Kadmon Holdings (KDMN) United States $0.364B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.346B 0.00
Precision BioSciences (DTIL) United States $0.345B 0.00
AC Immune SA (ACIU) Switzerland $0.334B 24.75
CytomX Therapeutics (CTMX) United States $0.323B 0.00
Prothena (PRTA) Ireland $0.320B 0.00
Protagonist Therapeutics (PTGX) United States $0.317B 0.00
Avid Bioservices (CDMO) United States $0.299B 0.00
Gritstone Oncology (GRTS) United States $0.298B 0.00
Syros Pharmaceuticals (SYRS) United States $0.295B 0.00
Kindred Biosciences (KIN) United States $0.292B 0.00
Cellular Biomedicine (CBMG) United States $0.287B 0.00
Geron (GERN) United States $0.281B 0.00
Scholar Rock Holding (SRRK) United States $0.280B 0.00
Starpharma Holdings (SPHRY) Australia $0.279B 0.00
PDL BioPharma (PDLI) United States $0.278B 7.15
Dynavax Technologies (DVAX) United States $0.276B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.271B 0.00
Biofrontera AG (BFRA) Germany $0.265B 395.33
Theratechnologies (THTX) Canada $0.263B 0.00
ADMA Biologics Inc (ADMA) United States $0.262B 0.00
Puma Biotechnology (PBYI) United States $0.260B 0.00
Seres Therapeutics (MCRB) United States $0.243B 0.00
MannKind (MNKD) United States $0.243B 0.00
Inovio Pharmaceuticals (INO) United States $0.234B 0.00
OSMOTICA PHARM (OSMT) United States $0.232B 0.00
Sutro Biopharma (STRO) United States $0.230B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.230B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Albireo Pharma (ALBO) United States $0.227B 0.00
Sorrento Therapeutics (SRNE) United States $0.219B 0.00
Kamada (KMDA) Israel $0.213B 8.14
Spero Therapeutics (SPRO) United States $0.212B 0.00
Athersys (ATHX) United States $0.211B 0.00
Exicure (XCUR) United States $0.205B 0.00
Compugen (CGEN) Israel $0.205B 0.00
POXEL SA FRANCE (PXXLF) France $0.204B 0.00
Clovis Oncology (CLVS) United States $0.200B 0.00
ChromaDex (CDXC) United States $0.198B 0.00
Affimed (AFMD) Germany $0.191B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.189B 0.00
Prometic Life Sciences (PFSCF) Canada $0.177B 0.00
Dyadic (DYAI) United States $0.177B 0.00
Nicox SA (NICXF) France $0.175B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.170B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Senesco Technologies (ELOX) United States $0.164B 0.00
Cue Biopharma (CUE) United States $0.163B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
XOMA (XOMA) United States $0.161B 0.00
Enzo Biochem (ENZ) United States $0.154B 0.00
Cerecor (CERC) United States $0.153B 0.00
Arsanis (XFOR) United States $0.153B 0.00
Five Prime Therapeutics (FPRX) United States $0.150B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.148B 0.00
Alcobra (ARCT) United States $0.146B 0.00
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Acorda Therapeutics (ACOR) United States $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.121B 0.00
NantKwest (NK) United States $0.119B 0.00
Emmaus Life Sciences (EMMA) United States $0.118B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.117B 0.00
PHASEBIO PHARMA (PHAS) United States $0.116B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.113B 0.00
Abeona Therapeutics (ABEO) United States $0.111B 0.00
Novavax (NVAX) United States $0.111B 0.00
Menlo Therapeutics (MNLO) United States $0.110B 0.00
Aptinyx (APTX) United States $0.109B 0.00
Strongbridge Biopharma (SBBP) United States $0.109B 4.47
Adaptimmune Therapeutics (ADAP) United Kingdom $0.105B 0.00
Windtree Therapeutics (WINT) United States $0.103B 0.00
OvaScience (MLND) United States $0.097B 0.00
Celyad SA (CYAD) Belgium $0.097B 0.00
VBI Vaccines (VBIV) United States $0.096B 0.00
Fortress Biotech (FBIO) United States $0.090B 0.00
Trevena (TRVN) United States $0.089B 0.00
Liquidia Technologies (LQDA) United States $0.089B 0.00
Antibe Therapeutics (ATBPF) Canada $0.087B 0.00
Aduro Biotech (ADRO) United States $0.087B 0.00
Adocia (ADOCY) France $0.086B 0.00
Verastem (VSTM) United States $0.084B 0.00
Vaccinex (VCNX) United States $0.083B 0.00
Mersana Therapeutics (MRSN) United States $0.079B 0.00
Idera Pharmaceuticals (IDRA) United States $0.078B 0.00
Checkpoint Therapeutics (CKPT) United States $0.078B 0.00
VTv Therapeutics (VTVT) United States $0.077B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.077B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.074B 0.00
ARAVIVE, INC (ARAV) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.072B 0.00
Curis (CRIS) United States $0.071B 0.00
Synlogic (SYBX) United States $0.070B 0.00
Catalyst Biosciences (CBIO) United States $0.067B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.065B 0.00
Selecta Biosciences (SELB) United States $0.063B 0.00
Orgenesis (ORGS) United States $0.060B 21.82
AquaBounty Technologies (AQB) United States $0.057B 0.00
Pluristem Therapeutics (PSTI) Israel $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.057B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.056B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.054B 0.00
Arbutus Biopharma (ABUS) Canada $0.053B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.051B 0.00
Unum Therapeutics (UMRX) United States $0.051B 0.00
VistaGen Therapeutics (VTGN) United States $0.050B 0.00
AIT Therapeutics (XAIR) United States $0.048B 0.00
NewLink Genetics (NLNK) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.047B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Evogene (EVGN) Israel $0.042B 0.00
Ophthotech (ISEE) United States $0.041B 0.00
Stellar Biotechnologies (EDSA) Canada $0.038B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.037B 0.00
Proteostasis Therapeutics (PTI) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
Oncobiologics (OTLK) United States $0.037B 0.00
Celsion (CLSN) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Clearside Biomedical (CLSD) United States $0.031B 0.00
Aptevo Therapeutics (APVO) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.87
BioCardia (BCDA) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.027B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Soligenix (SNGX) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.017B 0.00
Bionano Genomics (BNGO) United States $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
Pulmatrix (PULM) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Cleveland BioLabs (CBLI) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
TrovaGene (TROV) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Neuralstem (CUR) United States $0.003B 0.00